AR035449A1 - Preparacion y aislamiento de indolocarbazol glicosidos - Google Patents

Preparacion y aislamiento de indolocarbazol glicosidos

Info

Publication number
AR035449A1
AR035449A1 ARP020101110A ARP020101110A AR035449A1 AR 035449 A1 AR035449 A1 AR 035449A1 AR P020101110 A ARP020101110 A AR P020101110A AR P020101110 A ARP020101110 A AR P020101110A AR 035449 A1 AR035449 A1 AR 035449A1
Authority
AR
Argentina
Prior art keywords
glycosides
indolocarbazol
isolation
preparation
compound
Prior art date
Application number
ARP020101110A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Banyu Pharma Co Ltd filed Critical Merck & Co Inc
Publication of AR035449A1 publication Critical patent/AR035449A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/22Pteridine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un proceso para fabricar indolocarbazol glicósidos en elevada pureza, que inhiben el crecimiento de células tumorales y, por lo tanto, son útiles en el tratamiento del cáncer en mamíferos, y similares. Un proceso para preparar cristales del compuesto (1), en elevada pureza, que comprende los pasos de: (a) ajustar el pH de una mezcla ácida que consiste, en esencia, de un alcohol, un ácido, agua y el compuesto (1), mediante el agregado de una base para producir una solución con un pH en el rango de aproximadamente 1,5 a aproximadamente 6,5; (b) mantener la temperatura de la solución del paso (a) en el rango de aproximadamente 50°C a aproximadamente 100°C; y (c) aislar los cristales del compuestos (1).
ARP020101110A 2001-03-29 2002-03-26 Preparacion y aislamiento de indolocarbazol glicosidos AR035449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962901P 2001-03-29 2001-03-29

Publications (1)

Publication Number Publication Date
AR035449A1 true AR035449A1 (es) 2004-05-26

Family

ID=23069774

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101110A AR035449A1 (es) 2001-03-29 2002-03-26 Preparacion y aislamiento de indolocarbazol glicosidos

Country Status (22)

Country Link
US (2) US6559299B2 (es)
EP (1) EP1390376A1 (es)
JP (1) JP3439470B1 (es)
KR (1) KR20040028732A (es)
CN (1) CN1268633C (es)
AR (1) AR035449A1 (es)
AU (1) AU2002306863B2 (es)
BR (1) BR0208470A (es)
CA (1) CA2441214A1 (es)
CZ (1) CZ20032638A3 (es)
EA (1) EA005126B1 (es)
HR (1) HRP20030777A2 (es)
HU (1) HUP0303640A2 (es)
IL (1) IL157823A0 (es)
MX (1) MXPA03008805A (es)
NZ (1) NZ529168A (es)
PL (1) PL363865A1 (es)
SK (1) SK11972003A3 (es)
TW (1) TWI245045B (es)
UA (1) UA74249C2 (es)
WO (1) WO2002079214A1 (es)
YU (1) YU72603A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559299B2 (en) * 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides
WO2005010018A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd. 結晶形態の6−n−ピリジルメチルアミノインドロカルバゾール化合物
US20060227241A1 (en) * 2005-04-06 2006-10-12 Dyke Phil V Apparatus and method for adjusting colors of an image

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591842A (en) 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5437996A (en) 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5589365A (en) 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
US5804564A (en) 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5922860A (en) 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US6559299B2 (en) * 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides

Also Published As

Publication number Publication date
KR20040028732A (ko) 2004-04-03
UA74249C2 (uk) 2005-11-15
AU2002306863B2 (en) 2007-08-09
CN1578784A (zh) 2005-02-09
YU72603A (sh) 2006-05-25
BR0208470A (pt) 2004-03-02
US20040116688A1 (en) 2004-06-17
IL157823A0 (en) 2004-03-28
EP1390376A1 (en) 2004-02-25
NZ529168A (en) 2005-03-24
US20020193324A1 (en) 2002-12-19
TWI245045B (en) 2005-12-11
EA200301068A1 (ru) 2004-02-26
WO2002079214A1 (en) 2002-10-10
EA005126B1 (ru) 2004-12-30
JP3439470B1 (ja) 2003-08-25
CZ20032638A3 (cs) 2004-02-18
HRP20030777A2 (en) 2005-08-31
PL363865A1 (en) 2004-11-29
US6559299B2 (en) 2003-05-06
MXPA03008805A (es) 2004-10-15
HUP0303640A2 (hu) 2004-03-01
SK11972003A3 (sk) 2004-01-08
CA2441214A1 (en) 2002-10-10
JP2004519518A (ja) 2004-07-02
CN1268633C (zh) 2006-08-09

Similar Documents

Publication Publication Date Title
ES2638319T3 (es) Imidazopiridazinas sustituidas con amino
CR20110380A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal (divisional exp. 8266)
US20190194105A1 (en) Prenylated hydroxystilbenes
PE20001333A1 (es) Proceso para estabilizar macrolidos de polieno
AR006108A1 (es) Pirimido[5,4-d]pirimidinas, sus sales fisiologicamente compatibles, un procedimiento para su preparacion, su empleo para la preparacion de composiciones farmaceuticas, y las composiciones farmaceuticas que las contienen
SE435514B (sv) Forfarande for framstellning av 4'-deoxiadriamycin hydroklorid
GT200100016A (es) Pirido[2,3,-d]pirimidin-2,7-diaminas inhibidoras de cinasas.
UY27924A1 (es) Compuestos tipo diarilureas fluoradas
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
HUP0202536A2 (hu) A pravasztatin nátrium-sójának kristályai
AR052860A1 (es) Intermediario y proceso para preparar anomeros beta-enriquecidos de 21-deoxi,21, 21-difluoro-d-ribofuranosil nucleosidos
AR057291A1 (es) Proceso para la preparacion de acidos bisfosfonicos geminales y las sales y/o hidratos farmaceuticamente aceptables de los mismos, una composicion farmaceutica que los contiene y el uso de esta en el tratamiento de la osteoporosis
BR0115036A (pt) Processo para a preparação de um composto
WO2020198323A1 (en) Prmt5 inhibitors and uses thereof
PE20000477A1 (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo[4.3.0)nonano
AR035449A1 (es) Preparacion y aislamiento de indolocarbazol glicosidos
HU194269B (en) Process for producing new 20-amino-tylosine derivatives
CA2335995A1 (en) Inhibitors of phosphatidyl myo-inositol cycle
AR026453A1 (es) Procedimiento para la preparacion de cetiminas
US4935529A (en) Cytoxic substances from the marine cyanophyte hormothamnion enteromorphoides grunow
PE20020289A1 (es) Compuestos con nucleos heterociclico-hidroximino-fluoreno y composiciones farmaceuticas que los contienen como inhibidores de las proteinas cinasas
WO2006119402A3 (en) C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
JPS57212200A (en) Preparation of echinoside a
KR20070048700A (ko) (s,s)-이성질체가 풍부한s-아데노실-l-메티오닌의 화학 합성
AR032589A1 (es) Proceso para preparar pirazoles 1,5-diaril-3-sustituidos y proceso para preparar compuestos intermediarios

Legal Events

Date Code Title Description
FC Refusal
FA Abandonment or withdrawal